Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats.
about
Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.Distinct cardiac transcriptional profiles defining pregnancy and exerciseActivation of the aryl hydrocarbon receptor by doxorubicin mediates cytoprotective effects in the heartA discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor.Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl/6 mice.The effects of cytochrome P450 induction by xenobiotics on endobiotic metabolism in pre-clinical safety studies.20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertensionMechanisms and management of doxorubicin cardiotoxicity.The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy.The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol.Cardioprotective effects of curcumin-loaded magnetic hydrogel nanocomposite (nanocurcumin) against doxorubicin-induced cardiac toxicity in rat cardiomyocyte cell lines.Development of cellular hypertrophy by 8-hydroxyeicosatetraenoic acid in the human ventricular cardiomyocyte, RL-14 cell line, is implicated by MAPK and NF-κB.5-, 12- and 15-Hydroxyeicosatetraenoic acids induce cellular hypertrophy in the human ventricular cardiomyocyte, RL-14 cell line, through MAPK- and NF-κB-dependent mechanism.Strain echocardiography in early detection of Doxorubicin-induced left ventricular dysfunction in children with acute lymphoblastic leukemia.Acute arsenic treatment alters arachidonic acid and its associated metabolite levels in the brain of C57Bl/6 mice.Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associated arachidonic acid metabolism in C57Bl/6 mouse heart.Differential modulation of aryl hydrocarbon receptor regulated enzymes by arsenite in the kidney, lung, and heart of C57BL/6 mice.Boswellic acids synergize antitumor activity and protect against the cardiotoxicity of doxorubicin in mice bearing Ehrlich's carcinoma.Arachidonic Acid Metabolism by Human Cardiovascular CYP2J2 Is Modulated by Doxorubicin.Mode of treatment governs curcumin response on doxorubicin-induced toxicity in cardiomyoblasts.The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.The Physiopathology of Cardiorenal Syndrome: A Review of the Potential Contributions of Inflammation.2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy.CYP2J2 expression in adult ventricular myocytes protects against external and drug induced ROS toxicity.The interplay between genetic background and sexual dimorphism of doxorubicin-induced cardiotoxicity.CYP2J2 - regulation, function and polymorphism.Cardioprotective effect of magnetic hydrogel nanocomposite loaded N,α-L-rhamnopyranosyl vincosamide isolated from Moringa oleifera leaves against doxorubicin-induced cardiac toxicity in rats: in vitro and in vivo studies.Microarray and Co-expression Network Analysis of Genes Associated with Acute Doxorubicin Cardiomyopathy in Mice.Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity
P2860
Q34358307-CDC5B1BB-10E7-474B-A3AA-32B90C704683Q34364776-3C85FE91-1300-43A2-A6E6-BC9226D14A4BQ34808490-4E532B51-1EB5-41AD-A4BC-D09235C304AFQ37293202-DC7BD105-0C5C-44C8-B509-1722C36E887DQ37340856-509AF3C1-F6CF-4485-A37B-8E47A1E557E3Q37569491-E969C997-48EA-413A-928E-8B48A16334B3Q37706625-F0D8180F-D097-4512-B090-2555E4BC5EA0Q37798679-83E65F97-7AEB-471C-9403-F290D73EF6B2Q38473474-516CE66C-E516-47D3-86FA-95B267C1A88CQ38622658-A4A9FD34-42A3-498E-82E6-093937057638Q38714257-31ADB2BE-C484-4A09-92B9-BF165BDC92B5Q38727333-D0A94F94-26CC-499E-BFEC-5C8374CA4D1AQ38825803-44E13575-E161-49AB-A868-ED7B13D2B213Q38918680-4F0DCA36-99FB-4B74-9292-49E24F0FCCB4Q42019686-2AAE6BEB-2FE5-4AC9-8905-945CC20FD55AQ42704683-040AE5E4-AE2C-4ABD-A4C9-65FE49379525Q42717628-17030388-833C-4D0C-90AD-612939AD3106Q42718641-0CEECA73-AE22-49BE-B45A-4004FD21A5DDQ46210824-68640D20-C7ED-400B-8DE9-D3175BE7A358Q46249034-29A7BD66-5C53-4221-93EF-C077A93A1646Q46304110-84B044BF-51BA-4646-8DB2-B2F3D3716D62Q47339443-4099ABBE-C596-4E2F-B85A-B42B3AC1CB68Q48172048-B889C8C0-5FD4-4CC3-A4B4-1823B132966EQ49185697-6F7A0179-D5EF-4DA9-B68C-ACBF458858CFQ49989932-B0CEB6F4-0954-43C4-9718-01F7225584BAQ50946920-88CECB4E-746B-43EF-B759-88C853384DCEQ51709663-004458CB-51D4-4D93-9E7F-662C08FB45F8Q52682271-92EBCE06-2375-426B-8AD4-57F45BFCA57AQ53641268-123DC5B1-BDC0-4CEC-A160-22D7FB656368Q58696664-764D6CE4-E36B-4790-A876-A47621C184B7
P2860
Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Acute doxorubicin cardiotoxici ...... donic acid metabolism in rats.
@en
Acute doxorubicin cardiotoxici ...... donic acid metabolism in rats.
@nl
type
label
Acute doxorubicin cardiotoxici ...... donic acid metabolism in rats.
@en
Acute doxorubicin cardiotoxici ...... donic acid metabolism in rats.
@nl
prefLabel
Acute doxorubicin cardiotoxici ...... donic acid metabolism in rats.
@en
Acute doxorubicin cardiotoxici ...... donic acid metabolism in rats.
@nl
P1476
Acute doxorubicin cardiotoxici ...... donic acid metabolism in rats.
@en
P2093
Ayman O S El-Kadi
Beshay N M Zordoky
P356
10.1016/J.TAAP.2009.09.012
P577
2009-09-29T00:00:00Z